(Q51036907)

27 March 2018

title

Rituximab monotherapy as a first-line treatment for pulmonary mucosa-associated lymphoid tissue lymphoma (English)

1 reference

27 March 2018

1 reference

1 reference

27 March 2018

author name string

Hisao Imai

1 reference

27 March 2018

Keita Mori

1 reference

27 March 2018

Kazuto Ogura

1 reference

27 March 2018

Atsushi Isoda

1 reference

27 March 2018

Keichiro Mihara

1 reference

27 March 2018

Morio Matsumoto

1 reference

27 March 2018

Ryusei Saito

1 reference

27 March 2018

Toshiaki Takahashi

1 reference

27 March 2018

Takashi Ikeda

1 reference

27 March 2018

publication date

7 November 2014

1 reference

27 March 2018

International Journal of Hematology

published in

1 reference

27 March 2018

volume

101

1 reference

27 March 2018

issue

1 reference

27 March 2018

page(s)

46-51

1 reference

27 March 2018

Prevalence of Achromobacter xylosoxidans in pulmonary mucosa-associated lymphoid tissue lymphoma in different regions of Europe

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1694-8

Bronchial-associated lymphoid tissue lymphoma: a clinical study of a rare disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1694-8

Monoclonal antibody therapy for B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1694-8

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1694-8

Rituximab for treatment of advanced extranodal marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1694-8

Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1694-8

Extended rituximab schedules may result in increased efficacy in pulmonary malt lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1694-8

Staging non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1694-8

Addition of rituximab to chlorambucil produces superior event-free survival in the treatment of patients with extranodal marginal-zone B-cell lymphoma: 5-year analysis of the IELSG-19 Randomized Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1694-8

Low-grade B-cell bronchial associated lymphoid tissue (BALT) lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1694-8

Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1694-8

Stage I and II MALT lymphoma: results of treatment with radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1694-8

Extranodal marginal zone B-cell lymphoma of the lung: experience with fludarabine and mitoxantrone-containing regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1694-8

Clinical characteristics and prognostic factors of pulmonary MALT lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1694-8

Pulmonary BALT Lymphoma Successfully Treated with Eight Cycles Weekly Rituximab: Report of First Case and F-18 FDG PET/CT Images

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1694-8

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group

21 January 2018

1 reference

12 December 2020

Treatment of mucosa-associated lymphoid tissue lymphoma of the stomach with radiation alone

1 reference

12 December 2020

Treatment outcome of mucosa-associated lymphoid tissue/marginal zone non-Hodgkin's lymphoma

1 reference

12 December 2020

Pathologic and clinical features of primary pulmonary extranodal marginal zone B-cell lymphoma of MALT type

1 reference

12 December 2020

Association of serum Rituximab (IDEC-C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin's lymphoma

1 reference

12 December 2020

The gastric marginal zone B-cell lymphoma of MALT type.

1 reference

12 December 2020

Primary malignant lymphoma of the lung: Histopathologic and immunologic evaluation of nine cases

1 reference

12 December 2020

Reactive pulmonary lymphoid disorders

1 reference

12 December 2020

Primary pulmonary lymphomas. A clinical study of 70 cases in nonimmunocompromised patients

1 reference

12 December 2020

Mechanism of action of rituximab

1 reference

12 December 2020

Primary pulmonary lymphoma: a re-appraisal of its histogenesis and its relationship to pseudolymphoma and lymphoid interstitial pneumonia

1 reference

12 December 2020

Mucosa-associated lymphoid tissue gastrointestinal and nongastrointestinal lymphoma behavior: analysis of 108 patients.

1 reference

12 December 2020

Clinicopathological features of patients with bronchial-associated lymphoid tissue lymphoma

1 reference

12 December 2020

Primary pulmonary lymphoma

1 reference

12 December 2020

Efficacy of single-agent chemotherapy in low-grade B-cell mucosa-associated lymphoid tissue lymphoma with prominent gastric expression

1 reference

12 December 2020

1 reference

12 December 2020

Clinical features, treatment and outcome in a series of 93 patients with low-grade gastric MALT lymphoma

1 reference

12 December 2020

Primary non-Hodgkin's lymphoma of the lung

1 reference

12 December 2020

Primary lymphomas of the lung: morphological, immunohistochemical and clinical features

1 reference

12 December 2020

Nongastrointestinal low-grade mucosa-associated lymphoid tissue lymphoma: analysis of 75 patients

1 reference

12 December 2020

PULMONARY MALIGNANT LYMPHOMAS AND PSEUDOLYMPHOMAS: CLASSIFICATION, THERAPY, AND PROGNOSIS

1 reference

12 December 2020

Primary non-Hodgkin's lymphoma and pseudolymphoma of lung: a study of 161 patients

1 reference

12 December 2020

Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma

1 reference

12 December 2020

Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed

1 reference

12 December 2020

10.1007/S12185-014-1694-8

Identifiers

DOI

1 reference

27 March 2018

1 reference

27 March 2018